The COVID-19 pandemic took a deadlier and more devastating turn in 2021 soon after a glimmer of hope was provided by the launch of vaccines at the beginning of the year, etching nightmarish......
Bharat Biotech's Covaxin is likely to be the only COVID-19 vaccine available, for now, for children in the age group of 15-18 years, who will be inoculated from January 3, official sources said.......
Only half India's population has received the first shot of Covishield and Covaxin and the government's immediate task is to first vaccinate its adult population before placing its focus on......
Drug firm Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Indian drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture......
While Bharat Biotech’s Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been......
From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies — Indian drug makers have......
The procurement and distribution will be centralised though the government is yet to take a call on the initial number of doses that will be procured. India plans to create a digital......
Zydus plans to initiate the clinical trials of ZyCoV-D in July 2020 across multiple sites in India. In animal studies the vaccine was found to elicit a strong immune response in multiple animal......
Can Interferon alfa-2b treat COVID-19 effectively?Sohini Dutt reports. Kindly note the image has been posted only for representational purposes. Photograph: PTI Photo Ahmedabad-based......
A glance back at some important ups and down India Inc faced in 2018. Year End Specials Kindly click on the image below to view the relevant story. #1 How PNB scam effected consumer......